Endogenous leukemia inhibitory factor attenuates endotoxin response

被引:45
作者
Weber, MA
Schnyder-Candrian, S
Schnyder, B
Quesniaux, V
Poli, V
Stewart, CL
Ryffel, B
机构
[1] CNRS, F-45071 Orleans, France
[2] NCI, Canc & Dev Biol Lab, FCRDC, Frederick, MD USA
[3] Univ Turin, Dipartimento Genet Biol & Biochim, I-10124 Turin, Italy
关键词
LPS; LIF-deficient mice; endotoxic shock; LIF; TNF; IL-6; acute phase;
D O I
10.1038/labinvest.3700216
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Leukemia inhibitory factor (LIF) is induced in inflammation and likely plays a regulatory role. Using LIF-deficient mice ( LIF -/-), we report here that endogenous LIF has a protective role in endotoxic shock and host defence. LIF -/- mice have heightened sensitivity to LPS in a LPS/D-galactosamine (D-Gal) sensitization model compared to wild-type mice ( LIF+/+), enhanced thrombocytopenia and leukopenia, with increased hepatic necrosis, neutrophil sequestration in the lung and accelerated mortality. These findings correlated with 10-fold higher tumour necrosis factor-alpha (TNFalpha) and interleukin-6 ( IL-6) serum levels and reduced IL-10 production in LIF -/- mice in response to LPS. Therefore, endogenous LIF attenuates the endotoxic shock response, enhances the expression of basal acute phase proteins and IL-10 production, which downregulates TNFalpha synthesis and release and thereby confers partial protection to endotoxemia.
引用
收藏
页码:276 / 284
页数:9
相关论文
共 43 条
[1]  
ADERKA D, 1989, J IMMUNOL, V143, P3517
[2]   THE ACUTE-PHASE RESPONSE PROTECTS MICE FROM D-GALACTOSAMINE SENSITIZATION TO ENDOTOXIN AND TUMOR-NECROSIS-FACTOR-ALPHA [J].
ALCORN, JM ;
FIERER, J ;
CHOJKIER, M .
HEPATOLOGY, 1992, 15 (01) :122-129
[3]   DIFFERENTIATION FACTOR LEUKEMIA INHIBITORY FACTOR PROTECTION AGAINST LETHAL ENDOTOXEMIA IN MICE - SYNERGISTIC EFFECT WITH INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR [J].
ALEXANDER, HR ;
WONG, GGH ;
DOHERTY, GM ;
VENZON, DJ ;
FRAKER, DL ;
NORTON, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (04) :1139-1142
[4]   D-FACTOR LEUKEMIA INHIBITORY FACTOR - EVIDENCE FOR ITS ROLE AS A MEDIATOR IN ACUTE AND CHRONIC INFLAMMATORY DISEASE [J].
ALEXANDER, HR ;
BILLINGSLEY, KG ;
BLOCK, MI ;
FRAKER, DL .
CYTOKINE, 1994, 6 (06) :589-596
[5]  
ALEXANDER HR, 1991, J SURG RES, V50, P421
[6]   PROTECTIVE ROLE OF INTERLEUKIN-6 IN THE LIPOPOLYSACCHARIDE-GALACTOSAMINE SEPTIC SHOCK MODEL [J].
BARTON, BE ;
JACKSON, JV .
INFECTION AND IMMUNITY, 1993, 61 (04) :1496-1499
[7]   PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].
BEUTLER, B ;
MILSARK, IW ;
CERAMI, AC .
SCIENCE, 1985, 229 (4716) :869-871
[8]   PASSIVE-IMMUNIZATION OF MICE AGAINST D-FACTOR BLOCKS LETHALITY AND CYTOKINE RELEASE DURING ENDOTOXEMIA [J].
BLOCK, MI ;
BERG, M ;
MCNAMARA, MJ ;
NORTON, JA ;
FRAKER, DL ;
ALEXANDER, HR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (03) :1085-1090
[9]   ENDOGENOUS D-FACTOR ACTIVITY PARTIALLY MEDIATES THE TOXIC BUT NOT THE THERAPEUTIC EFFECTS OF TUMOR-NECROSIS-FACTOR [J].
BLOCK, MI ;
FRAKER, DL ;
STRASSMANN, G ;
BILLINGSLEY, KG ;
ARNOLD, WS ;
PERLIS, C ;
ALEXANDER, HR .
INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (02) :245-249
[10]   INTERFERON-GAMMA RECEPTOR-DEFICIENT MICE ARE RESISTANT TO ENDOTOXIC-SHOCK [J].
CAR, BD ;
ENG, VM ;
SCHNYDER, B ;
OZMEN, L ;
HUANG, S ;
GALLAY, P ;
HEUMANN, D ;
AGUET, M ;
RYFFEL, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (05) :1437-1444